dexamethasone cyclodextrin nanoparticle ophthalmic suspension (OCS-01) - Oculis
DIAMOND-2: A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 2) (clinicaltrials.gov) - Jun 9, 2025 - P3 | N=401 | Active, not recruiting | Sponsor: Oculis | Recruiting ➔ Active, not recruiting 
Enrollment closed • Diabetic Macular Edema • Ophthalmology
http://clinicaltrials.gov/ct2/show/NCT06172257
 
Jun 9, 2025
 
Prev Next